Gartner Blog Network

New Research: Is It Time for Life Science CIOs to Enable Digital Monetization?

by Stephen Davies  |  December 21, 2017  |  Submit a Comment

Digital does monetize. That is an absolute certainty. The 2017 Forbes 400 list of wealthiest individuals includes four “digital” billionaires in the top 10. The founders of Amazon, Facebook and Google had a combined net worth exceeding $240 billion when the Forbes article was published on October 17th, 2017. Twenty years ago the combined net worth of the top 20 individuals on the 1997  Forbes 400 list was only $188 billion. Bezos, Zuckerberg, Page, and Brin were not on the 1997 list since their companies were either very new (Amazon was founded in 1994) or not even founded (Google was founded in 1998 and Facebook in 2004).

Gartner’s recently published research explores the topic of digital monetization in life science. Our analyst team predicts five provocative events;  acquisition of a life science company, revenue-driving life science digital products and services, relinquishment of life science mobile apps, blockchain projects and real-world data solutions. Life science CIOs can use these strategic planning assumptions to guide priorities, investments and leadership actions.


Title: Predicts 2018: Is It Time for Life Science CIOs to Enable Digital Monetization?

Summary: Life science CIOs are often asked by functional leaders how new digital solutions can deliver quantitative results for the company. These CIOs can drive transformational change by delivering digital products and services with a potential for monetization.

Contact Gartner to discuss these predictions with one of our life science analysts.

Gartner Clients: Click here to make sure you are tracking the life science initiative “Leveraging Digital Strategies for Life Science R&D and Commercial Impact”


Additional Resources

View Free, Relevant Gartner Research

Gartner's research helps you cut through the complexity and deliver the knowledge you need to make the right decisions quickly, and with confidence.

Read Free Gartner Research

Category: digital  life-sciences  medical-devices  multichannel-marketing  new-research  pharma-biotech  

Tags: biotech  blockchain  cio  digital  multichannel  pharma  pharmaceutical  

Stephen Davies
Research Director
4 years at Gartner
32 years IT Industry

Stephen Davies is a member of the Healthcare team within the Industries Research organization. He covers the technology aspects of commercialization topics (CRM, revenue management, contract management, compliance) for the life sciences area. Read Full Bio

Leave a Reply

Your email address will not be published. Required fields are marked *

Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.